Abstract
Purpose
Increasing evidence indicates that the microbiome may influence tumor growth and modulate the tumor microenvironment of gastrointestinal cancers. However, the role of oral bacteria in the development of esophageal squamous cell carcinoma (EsoSCC) has remained unclear. Herein, we investigated the relationship between the periodontal pathogen Porphyromonas gingivalis and EsoSCC.
Methods
To identify bacterial biomarkers associated with EsoSCC, we analyzed microbiomes in oral biofilms. The presence of P. gingivalis in esophageal tissues and relationships of P. gingivalis infection with clinicopathologic characteristics in 156 patients with EsoSCC were assessed using immunohistochemistry. The role of P. gingivalis infection in in vitro and in vivo EsoSCC progression was also assessed.
Results
Microbiota profiles in oral biofilms revealed that P. gingivalis abundance was associated with an increased risk of EsoSCC development. In total, 57% of patients with EsoSCC were found to be infected with P. gingivalis. The presence of P. gingivalis was found to be associated with advanced clinical stages and a poor prognosis. It was also found to be associated with an elevated esophageal cancer incidence in a 4-nitroquinoline 1-oxide-induced mouse model and with an increased xenograft tumor growth. P. gingivalis infection increased interleukin (IL)‐6 production and it promoted epithelial-mesenchymal transition and the recruitment of myeloid-derived suppressor cells. Furthermore, inhibited IL‐6 signaling attenuated the tumor-promoting effects of P. gingivalis in 4-nitroquinoline 1-oxide-treated mice and xenograft mouse models.
Conclusions
Our data indicate that P. gingivalis may promote esophageal cancer development and progression. Direct targeting of P. gingivalis or concomitant IL-6 signaling may be a promising strategy to prevent and/or treat EsoSCC associated with P. gingivalis infection.
Similar content being viewed by others
References
P.C. Enzinger, R.J. Mayer, Esophageal cancer. N. Engl. J. Med. 349, 2241–2252 (2003)
C. Pottgen, M. Stuschke, Radiotherapy versus surgery within multimodality protocols for esophageal cancer–a meta-analysis of the randomized trials. Cancer Treat. Rev. 38, 599–604 (2012)
W.S. Garrett, Cancer and the microbiota. Science 348, 80–86 (2015)
A. Dzutsev, R.S. Goldszmid, S. Viaud, L. Zitvogel, G. Trinchieri, The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur. J. Immunol. 45, 17–31 (2015)
Y. Baba, M. Iwatsuki, N. Yoshida, M. Watanabe, H. Baba, Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications. Ann. Gastroenterol. Surg. 1, 99–104 (2017)
D. Nasrollahzadeh, R. Malekzadeh, A. Ploner, R. Shakeri, M. Sotoudeh, S. Fahimi, S. Nasseri-Moghaddam, F. Kamangar, C.C. Abnet, B. Winckler, F. Islami, P. Boffetta, P. Brennan, S.M. Dawsey, W. Ye, Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia. Sci. Rep. 5, 8820 (2015)
E. Elinav, R. Nowarski, C.A. Thaiss, B. Hu, C. Jin, R.A. Flavell, Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759–771 (2013)
S. Gao, S. Li, Z. Ma, S. Liang, T. Shan, M. Zhang, X. Zhu, P. Zhang, G. Liu, F. Zhou, X. Yuan, R. Jia, J. Potempa, D.A. Scott, R.J. Lamont, H. Wang, X. Feng, Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer. Infect. Agent. Cancer 11, 3 (2016)
K. Yamamura, Y. Baba, S. Nakagawa, K. Mima, K. Miyake, K. Nakamura, H. Sawayama, K. Kinoshita, T. Ishimoto, M. Iwatsuki, Y. Sakamoto, Y. Yamashita, N. Yoshida, M. Watanabe, H. Baba, Human microbiome Fusobacterium Nucleatum in esophageal cancer tissue is associated with prognosis. Clin. Cancer Res. 22, 5574–5581 (2016)
E. Norder Grusell, G. Dahlen, M. Ruth, L. Ny, M. Quiding-Jarbrink, H. Bergquist, M. Bove, Bacterial flora of the human oral cavity, and the upper and lower esophagus. Dis. Esophagus 26, 84–90 (2013)
D.S. Michaud, K.T. Kelsey, E. Papathanasiou, C.A. Genco, E. Giovannucci, Periodontal disease and risk of all cancers among male never smokers: An updated analysis of the Health Professionals Follow-up Study. Ann. Oncol. 27, 941–947 (2016)
N. Guha, P. Boffetta, V.W. Filho, J. Eluf Neto, O. Shangina, D. Zaridze, M.P. Curado, S. Koifman, E. Matos, A. Menezes, N. Szeszenia-Dabrowska, L. Fernandez, D. Mates, A.W. Daudt, J. Lissowska, R. Dikshit, P. Brennan, Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am. J. Epidemiol. 166, 1159–1173 (2007)
J.R. Siewert, H.J. Stein, M. Feith, B.L. Bruecher, H. Bartels, U. Fink, Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann. Surg. 234, 360–367; discussion 368–369 (2001)
A.G. Neto, A. Whitaker, Z. Pei, Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma. Semin. Oncol. 43, 86–96 (2016)
H. Xie, Biogenesis and function of Porphyromonas gingivalis outer membrane vesicles. Future Microbiol. 10, 1517–1512 (2015)
A. Amano, I. Nakagawa, N. Okahashi, N. Hamada, Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. J. Periodontal. Res. 39, 136–142 (2004)
K.R. Atanasova, O. Yilmaz, Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol. Oral. Microbiol. 29, 55–66 (2014)
X.H. Tang, B. Knudsen, D. Bemis, S. Tickoo, L.J. Gudas, Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin. Cancer Res. 10, 301–313 (2004)
M.F. Chen, F.C. Kuan, T.C. Yen, M.S. Lu, P.Y. Lin, Y.H. Chung, W.C. Chen, K.D. Lee, IL-6-stimulated CD11b + CD14 + HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget 5, 8716–8728 (2014)
P.T. Chen, C.C. Hsieh, C.T. Wu, T.C. Yen, P.Y. Lin, W.C. Chen, M.F. Chen, 1alpha,25-dihydroxyvitamin D3 inhibits esophageal squamous cell carcinoma progression by reducing IL6 signaling. Mol. Cancer Ther. 14, 1365–1375 (2015)
J.S. Wu, M. Zheng, M. Zhang, X. Pang, L. Li, S.S. Wang, X. Yang, J.B. Wu, Y.J. Tang, Y.L. Tang, X.H. Liang, Porphyromonas gingivalis promotes 4-nitroquinoline-1-oxide-induced oral carcinogenesis with an alteration of fatty acid metabolism. Front. Microbiol. 9, 2081 (2018)
D.J. McConkey, W. Choi, L. Marquis, F. Martin, M.B. Williams, J. Shah, R. Svatek, A. Das, L. Adam, A. Kamat, A. Siefker-Radtke, C. Dinney, Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 28, 335–344 (2009)
P.C. Hermann, S. Bhaskar, M. Cioffi, C. Heeschen, Cancer stem cells in solid tumors. Semin Cancer Biol 20, 77–84 (2010)
M.F. Chen, P.T. Chen, M.S. Lu, W.C. Chen, Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment. Mol. Carcinog. 57, 78–88 (2018)
M.F. Chen, P.T. Chen, M.S. Lu, P.Y. Lin, W.C. Chen, K.D. Lee, IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. Mol. Cancer 12, 26 (2013)
R.F. Schwabe, C. Jobin, The microbiome and cancer. Nat. Rev. Cancer 13, 800–812 (2013)
M. Belanger, P.H. Rodrigues, W.A. Dunn Jr., A. Progulske-Fox, Autophagy: a highway for Porphyromonas gingivalis in endothelial cells. Autophagy 2, 165–170 (2006)
B.A. Peters, J. Wu, Z. Pei, L. Yang, M.P. Purdue, N.D. Freedman, E.J. Jacobs, S.M. Gapstur, R.B. Hayes, J. Ahn, Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 77, 6777–6787 (2017)
C.C. Abnet, F. Kamangar, F. Islami, D. Nasrollahzadeh, P. Brennan, K. Aghcheli, S. Merat, A. Pourshams, H.A. Marjani, A. Ebadati, M. Sotoudeh, P. Boffetta, R. Malekzadeh, S.M. Dawsey, Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers. Prev. 17, 3062–3068 (2008)
X. Chen, B. Winckler, M. Lu, H. Cheng, Z. Yuan, Y. Yang, L. Jin, W. Ye, Oral Microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One 10, e0143603 (2015)
I. Lafuente Ibanez de Mendoza, X. Maritxalar Mendia, A.M. Garcia de la Fuente, G. Quindos Andres, Aguirre Urizar, Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. J. Periodontal. Res. 55, 13–22 (2020)
S.E. Whitmore, R.J. Lamont, Oral bacteria and cancer. PLoS Pathog. 10, e1003933 (2014)
H. Inaba, H. Sugita, M. Kuboniwa, S. Iwai, M. Hamada, T. Noda, I. Morisaki, R.J. Lamont, A. Amano, Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell. Microbiol. 16, 131–145 (2014)
F. Meng, R. Li, L. Ma, L. Liu, X. Lai, D. Yang, J. Wei, Dong. Ma, Z. Li, Porphyromonas gingivalis promotes, the motility of esophageal squamous cell carcinoma by activating NF-κB signaling pathway. Microbes Infect. 21, 296–304 (2019)
B. Malinowski, A. Węsierska, K. Zalewska, M.M. Sokołowska, W. Bursiewicz, M. Socha, M. Ozorowski, K. Pawlak-Osińska, M. Wiciński, The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer. Infect. Agent Cancer 14, 3 (2019)
J. Ahn, S. Segers, R.B. Hayes, Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 33, 1055–1058 (2012)
S.G. Gao, J.Q. Yang, Z.K. Ma, X. Yuan, C. Zhao, G.C. Wang, H. Wei, X.S. Feng, Y.J. Qi, Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma. BMC Cancer 18, 17 (2018)
K. Sampieri, R. Fodde, Cancer stem cells and metastasis. Semin. Cancer Biol. 22, 187–193 (2012)
H. Yu, D. Pardoll, R. Jove, STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9, 798–809 (2009)
J. New, S.M. Thomas, Autophagy‐dependent secretion: mechanism, factors secreted, and disease implications. Autophagy 15, 1682–1693 (2019)
P. Maycotte, K.L. Jones, M.L. Goodall, J. Thorburn, A. Thorburn, Autophagy supports breast cancer stem cell maintenance by regulating IL6 secretion. Mol. Cancer Res. 13, 651–658 (2015)
J. Schupp, F.K. Krebs, N. Zimmer, E. Trzeciak, D. Schuppan, A. Tuettenberg, Targeting myeloid cells in the tumor sustaining microenvironment. Cell. Immunol. 343, 103713 (2019)
Funding
This work was support by Chang Gung Memorial Hospital. Grant CMRPG6H0561-2 (to M.F. Chen).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 1.61 MB)
Rights and permissions
About this article
Cite this article
Chen, MF., Lu, MS., Hsieh, CC. et al. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma. Cell Oncol. 44, 373–384 (2021). https://doi.org/10.1007/s13402-020-00573-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-020-00573-x